Streetbeat News

Products Services

GSK

GSK plc and Flagship Pioneering have announced a $150 million collaboration to develop innovative health solutions, focusing initially on respiratory and immunology. The partnership aims to identify up to 10 novel medicines and vaccines, with GSK having exclusive options for further clinical development.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:09 am

ELDN

Eledon Pharmaceuticals has enrolled the 80th participant in its Phase 2 BESTOW trial of Tegoprubart, aimed at preventing rejection in kidney transplantation. The company is on track to complete enrollment by the end of the year.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:07 am

CGTX

Cognition Therapeutics, Inc. (NASDAQ:CGTX) reported positive Phase 2 results for its Alzheimer's drug, CT1812. Participants in the study showed cognitive improvement compared to placebo across various measures. The findings were presented at the Alzheimer's Association's International Conference.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:05 am

CGEN

Compugen has announced that the FDA has cleared the Investigational New Drug (IND) application for COM503, a treatment for solid tumors.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:04 am

SNDX

The FDA has extended the review period for Syndax Pharmaceuticals' leukemia drug Revumenib by three months, pushing the PDUFA action date to December 26, 2024. This extension is due to the submission of additional information, which was classified as a Major Amendment.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:03 am

TECH

Bio-techne announced its participation in Spear Bio's $45M Series A funding round. Spear Bio will use the proceeds to accelerate product development and scale its in-house manufacturing capacity.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:02 am

LI

TSLA

XPEV

Xiaomi Corp has acquired land in Beijing for $116 million to expand its EV production, aiming to produce a Tesla Model Y-like SUV by 2025. This move is part of a $10 billion plan to establish a strong presence in the EV sector. Chinese EV stocks XPeng Inc (NYSE:XPEV) and Li Auto Inc (NASDAQ:LI) are trading lower on Monday.

Portfolio Pulse from Anusuya Lahiri

July 29, 2024 | 11:01 am

LGVN

Longeveron shares are trading higher following the announcement of positive study results from the CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer's disease. The trial met its key objectives, supporting a favorable benefit/risk profile.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:59 am

AVXL

Anavex Life Sciences shares are trading higher after presenting data showing that their drug Blarcamesine significantly slowed clinical decline in early Alzheimer's disease patients. However, the functional co-primary endpoint, ADCS-ADL, did not reach significance at week 48.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:58 am

GH

Guardant Health shares are trading higher after the company announced that its Shield blood test for colorectal cancer screening received FDA approval.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:58 am